Congratulations to Margo Waters of the Nallathamby lab for having being selected for the Inaugural Woodward family endowment for excellence in NDnano undergraduate research! Margo has been an exceptional contributor to advancing research on novel cancer therapeutics in our lab. You can check out more about what motivates her at https://research.nd.edu/news/inaugural-woodward-family-endowment-for-excellence-in-ndnano-undergraduate-research-awarded/
Category Archive: AD&T Notre Dame
Jul 02
Inaugural Woodward family endowment for excellence in NDNANO undergraduate research awarded to Margo Waters
Categories:
AD&T Notre Dame, Berthiaume Institute for Precision Health, Cancer stem cells, Combination chemotherapy, Harper Cancer Research Institute, metastatic cancer cells
by Prakash
Tags: NDNano
Recent Posts
- Military Health Sciences Research Symposium 2024. (Aug 26-29, 2024, Kissimmee FL) August 30, 2024
- Sustained and Controlled Antibiotics Release for Prolonged Antibacterial Action Against MRSA, and Pseudomonas aeruginosa August 21, 2024
- Precision Health and Diagnostics Session Chair at Techconnect World Innovation Conference (2024) June 19, 2024
- MTEC Annual meeting in Baltimore MD (May 24, 2024) May 24, 2024
- Nallathamby Lab’s Kevin Armknecht is Invited to Present at the Midwest Microscopy and Microanalysis Workshop 2024 May 7, 2024
Archives
Categories
NIH Funding Opportunities
- Guidance on Salary Limitation for Grants and Cooperative Agreements FY 2025 April 3, 2025Notice NOT-OD-25-085 from the NIH Guide for Grants and Contracts
- NIH Operates Under a Continuing Resolution April 3, 2025Notice NOT-OD-25-084 from the NIH Guide for Grants and Contracts
- Notice to Extend the Expiration Date of PAR-23-220 SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required) April 3, 2025Notice NOT-OD-25-073 from the NIH Guide for Grants and Contracts
- Notice to Extend the Expiration Date of PAR-23-219 SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed) April 3, 2025Notice NOT-OD-25-072 from the NIH Guide for Grants and Contracts
- Implementation Update: Enhancing Security Measures for NIH Controlled-Access Data April 1, 2025Notice NOT-OD-25-083 from the NIH Guide for Grants and Contracts
- Notice to Extend the Expiration Date of PA-24-248 PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) April 1, 2025Notice NOT-OD-25-078 from the NIH Guide for Grants and Contracts
- Notice to Extend the Expiration Date of PA-24-247 PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) April 1, 2025Notice NOT-OD-25-077 from the NIH Guide for Grants and Contracts
- Notice to Extend the Expiration Date of PA-24-246 PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) April 1, 2025Notice NOT-OD-25-076 from the NIH Guide for Grants and Contracts
- Notice to Extend the Expiration Date of PA-24-245 PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) April 1, 2025Notice NOT-OD-25-075 from the NIH Guide for Grants and Contracts
Recent Comments